Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

Novo Nordisk A/S’s latest experimental obesity drug helped patients lose as much as 24.3% of their weight in a small study, ...

PARIS, June 21, 2025 (BSS/AFP) - A new generation of weight-loss drugs has proven remarkably effective, hugely popular and ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.

Eli Lilly's Mounjaro has seen a positive reception in India, capturing significant sales and market interest since its launch ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...